The UNSW RNA Institute is a world class RNA science, therapeutics and translational facility. Established with a $25 million investment from UNSW to build NSW’s capability to research, develop and manufacture RNA-based therapeutics locally.
At the heart of the UNSW RNA Institute lies the RNA Accelerator, its core facility pivotal in building up Australia’s own pipeline in RNA therapeutics. It is Australia’s first ISO 9001 Certified facility for the ‘Pilot-scale manufacture and design and development of new processes for RNA-based therapeutics and other products for pre-clinical studies.’ The RNA Accelerator supports all RNA industry and academia who need pre-clinical RNA production by developing technology in delivery vehicles, interactions and analytics, sensing, and manufacturing.
The Institute is also part of the NSW RNA Bioscience Alliance, a partnership across 14 universities in NSW and ACT and the NSW Government-funded $15 million NSW RNA Production and Research Network. The NSW Government has further invested $96 million in an RNA GMP pilot facility and committed $119 million to a 10-year RNA research plan.
Together, we’re building a world-leading manufacturing capability in NSW that will yield jobs, skills, and innovation in an industry with the potential to transform lives.